" A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis PT Lukey, SA Harrison, S Yang, Y Man… - European …, 2019 - Eur Respiratory Soc … in IPF lung. This study contributes not only to understanding of PI3K/mTOR inhibition in IPF, … relevance of attenuatin…